Home News & Events Events Events Filter events Filter events by clicking within the ‘Category’ drop-down list. Category - Any -IndustryWebinarsWorkshop Workshop Beginners/Intermediate Online NONMEM/PDx-Pop workshop Date 27 January 2026 - 28 January 2026 Time 09:00 - 16:00 Location Online/Virtual Webex Timezone America/New York Workshop Advanced Online NONMEM/PDx-Pop workshop Date 29 January 2026 Time 09:00 - 16:00 Location Online/Virtual Webex Timezone America/New York Industry SCOPE Date 2 February 2026 - 5 February 2026 Time 08:00 - 18:00 Location Orlando, FL, USA Timezone America/New York ICON will sponsor and speak Industry OCT West Coast Date 11 February 2026 - 12 February 2026 Time 08:00 - 18:00 Location Burlingame, CA, USA Timezone America/Los Angeles ICON will exhibit and speak | Booth #79 Industry ASCPT Date 4 March 2026 - 6 March 2026 Time 08:00 - 18:00 Location Denver, CO, USA Timezone America/Phoenix ICON will exhibit | Booth #29 Industry OCT Southeast Date 10 March 2026 - 11 March 2026 Time 08:00 - 18:00 Location RTP, NC, USA Timezone America/New York ICON will exhibit and speak | Booth #37 Industry BIO China Date 12 March 2026 - 14 March 2026 Time 08:00 - 18:00 Location Suzhou, China Timezone Asia/Hong Kong ICON will exhibit and speak Industry AD/PD Date 17 March 2026 - 21 March 2026 Time 08:00 - 18:00 Location Copenhagen, Denmark Timezone Europe/Copenhagen ICON will exhibit | Booth #29 Industry DIA Europe Date 24 March 2026 - 26 March 2026 Time 08:00 - 18:00 Location Rotterdam, NL Timezone Europe/Amsterdam ICON will speak 1 2 Next In this section In this section Press releases In the News Mediakit Facts and figures ICON spokespeople Awards Events Industry events Webinars Workshops Webinars Social media Connect with us Contact us Submit proposal request Update Email Preferences Global office locator ICON on social media Related information: Solutions Webinars Solutions Industry events Solutions Workshops What’s happening in ICON ICON Plc On January 5th, 2026, on the occasion of the visit of Irish Prime Minister Mr. Micheál Martin to China, ICON China team attended a business dinner hosted by the Irish government in Beijing. The event was held at the join... 16 Jan View post ICON Plc Missed our recent webinar from Symphony Health, an ICON plc company? The recording for Riding the data wave: How pharma can navigate disruptions in open claims is now available. Discover how life sciences organisatio... 16 Jan View post View webpage ICON Plc Learn the pros and cons of different AI models for SaMDs. The right model and data training sets are essential to develop your AI-enabled device. Our latest whitepaper lays out the best practices for data and AI models... 16 Jan View post View webpage ICON Plc What should you consider when choosing a training dataset for your AI-enabled SaMD? Our whitepaper has the answers. Learn about AI models and data best practices and plan for your FDA Pre-Sub. Download it today. https://... 16 Jan 2 View post View webpage ICON Plc With over 10,000 journals and conferences to consider it’s an important question to answer. There are 50+ accessible points of metadata to use in focusing your selection for a publishing source. Schedule a demo to learn ... 15 Jan View post View webpage ICON Plc Long-term follow-up for vaccines may seem to be a distant concern when clinical trials are just beginning, but it can be critical to have a plan for follow-up at the outset. Learn considerations for follow-up design, s... 15 Jan View post View webpage ICON Plc Potent and long-lasting incretin receptor agonists like GLP-1 RAs target the molecular mechanisms underlying glucose metabolism. Learn why these therapies are ushering in a new era of multi-indication drug development in... 15 Jan View post View webpage ICON Plc Deepali Suri shares her vision for the biotech sector in 2026 and beyond. With over two decades of experience across pharma, biotech, and CROs, she outlines a clear strategy to strengthen innovation, streamline develop... 14 Jan 2 View post View webpage ICON Plc Therapeutic developers can aid control of the HIV epidemic by creating simpler, longer-acting prevention methods that perform better in real-world settings. ICON's whitepaper details these advances and best practices for... 14 Jan 2 View post View webpage ICON Plc Demographic Matching in Organ Impairment Studies: Why It Matters Organ impairment (OI) studies are critical for safe and effective drug development—but did you know that demographic matching can make or break the accurac... 13 Jan View post View webpage ICON Plc In 2025 ICON was recognised in global rankings by both TIME and Fortune magazines celebrating organisations excelling in financial stability and environmental sustainability. Learn more. https://ow.ly/aqkw50XSPP5 13 Jan View post View webpage ICON Plc Continuing our series of articles discussing managing risk for medical devices, ICON’s regulatory expert Jeremy Tinkler turns his focus on the biological risk estimate and looks into the logical basis for the use of comp... 13 Jan View post View webpage
